BOSUTINIB vs BREMELANOTIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BOSUTINIB vs BREMELANOTIDE: Safety Overview
| Metric | BOSUTINIB | BREMELANOTIDE |
|---|---|---|
| Total FAERS Reports | 7,777 | 718 |
| Deaths Reported | 680 | 1 |
| Death Rate | 8.7% | 0.1% |
| Hospitalizations | 1,675 | 6 |
| Average Patient Age | 64.7 yrs | 48.2 yrs |
| % Female Patients | 51.8% | 94.8% |
| FDA Approval Date | May 23, 2025 | Jun 21, 2019 |
| Manufacturer | U.S. Pharmaceuticals | Palatin Technologies |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |